Therapeutic Antibody IND-enabling CMC Strategies for Bispecific Antibodies | ProBio CDMO 12-06-2022 / Rubin Jiang & Ian Chan IND-enabling CMC Strategies for Bispecific Antibodies Learn More
Cell & Gene Therapy Addressing analytical control challenges for different plasmid DNA products | ProBio CDMO 11-30-2022 / Lauren Lu, Senior Director of QC Dept Addressing analytical control challenges for different plasmid DNA products Learn More
Cell & Gene Therapy Development and manufacturing Strategy for DNA Base Vaccine-Drug Candidates | ProBio CDMO 11-01-2022 / Mark Wei, Sr. Director of Plasmid & Virus Process Development & Manufacturing Department, ProBio Biotech Since the outbreaks of COVID-19, DNA vaccines are promising in the SARS-CoV-2 vaccine race although they have a new platform technology that was not previously available on the market for human use. Learn More
Cell & Gene Therapy Scalable AAV Manufacturing Strategies | ProBio CDMO 07-14-2022 / Xiao Pan, Director of ProBio, Platform R&D Department Since the approval of the product Luxtura® using AAV as a vector in 2017, more and more clinical trials have been carried out rapidly, and various early clinical trial projects for rare diseases and a wide range of indications .. Learn More
Therapeutic Antibody Take the Accelerated Path Upstream with IND Compliant CHOK1-GenS Cell Line Development | ProBio CDMO 06-28-2022 / Ying Li, Director of Downstream Process Development, ProBio Learn More
Cell & Gene Therapy Lentiviral vector manufacturing using suspension cell line | ProBio CDMO 03-11-2021 / Dr. Mahmood Ali, Project Manager of Virus (R&D) Purification Process CGT has made a great breakthrough in the recent years, however the industry is facing challenges in developing stable and scalable manufacturing process for viral vectors. Learn More
Therapeutic Antibody Development of cell-based functional assay with high efficiency | ProBio CDMO 02-04-2021 / Lihao Wang, Senior Scientist of In Vitro Bioassay, ProBio Learn More
Therapeutic Antibody Practical issues and strategies of biological product technology transfer | ProBio CDMO 02-04-2021 / Aipeng Deng, Senior Scientist of MAST, ProBio Learn More